About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | A Phase 3 Clinical Study of KHK 4827

A Phase 3 Clinical Study of KHK 4827

NCT02052609·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Kyowa Kirin Co., Ltd.

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Subject has voluntarily signed the written informed consent form to participate in this study
Subject has completed the week 52 evaluation either in Study 003 or 004

You may not be if

Subject has had a serious infection, defined as requiring systemic treatment with antibiotics or antivirals (excluding oral administration)
Subject has been judged to be ineligible for participation in the study by the investigators/sub investigators

The record

StatusCompleted

PhasePhase 3

Taking part155

StartedFeb 2014

UpdatedAug 25, 2023

Conditions

Psoriasis Vulgaris Psoriatic Arthritis Pustular; Psoriasis, Palmaris Et Plantaris Psoriatic Erythroderma

Where1

For additional information regarding investigative sites for this trial, contact Kyowa Kirin
Chiyoda-ku, Tokyo, Japan